MicroRNA-34a regulates cardiac ageing and function.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Ageing is the predominant risk factor for cardiovascular diseases and contributes to a significantly worse outcome in patients with acute myocardial infarction. MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing. We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR 124, miR-34a/b/c, and miR-29a/b/c are upregulated in response to p53 activation and facilitate cellular senescence by downregulating survival and cell proliferation factors (Hermeking, 2010; Boon et al., 2013; Hu et al., 2014; Xu S. et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Boon et al., 2013
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Self-citationPervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Cited by
Items 301–400 of 828
Cardiac ageing: from hallmarks to therapeutic opportunities
Hastings, M. H., Zhou, Q., Wu, C., Shabani, P., Huang, S., Yu, X., Singh, A. P., Guseh, J. S., Li, H., Lerchenmüller, C., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae124 · Cited by 53
Huang, H., Tian, H., Duan, Z., Cao, Y., Zhang, X., & Sun, F. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.016 · Cited by 42
Ito, M., & Adachi‐Akahane, S. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13r09cp · Cited by 45
Tarantini, S., Giles, C. B., Wren, J. D., Ashpole, N. M., Valcarcel‐Ares, M. N., Wei, J. Y., Sonntag, W. E., Ungvari, Z. I., & Csiszár, A. (2016) · AGE · doi:10.1007/s11357-016-9943-9 · Cited by 43
Dicing the Disease with Dicer: The Implications of Dicer Ribonuclease in Human Pathologies
Theotoki, E. I., Pantazopoulou, V. I., Georgiou, S., Kakoulidis, P., Filippa, V., Stravopodis, D. J., & Anastasiadou, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197223 · Cited by 42
“During aging, Dicer has been found downregulated in different tissues, including brain [90,91], a reduction observed in DA neurons from PD patients [92].”
BackgroundTargeting microRNAs in heart failure
Duygu, B., Windt, L. J. D., & Martins, P. A. D. C. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.05.008 · Cited by 43
“The observed effects were attributed to angiogenesis induction in the border zone of the infarcted area and reduced DNA damage in cardiomyocytes [30].”
BackgroundHuman Cardiospheres as a Source of Multipotent Stem and Progenitor Cells
Barile, L., Gherghiceanu, M., Popescu, L. M., Moccetti, T., & Vassalli, G. (2013) · Stem Cells International · doi:10.1155/2013/916837 · Cited by 41
Plowright, A. T., Engkvist, O., Gill, A. L., Knerr, L., & Wang, Q. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307034 · Cited by 43
Non-coding RNAs in cardiovascular ageing
Gupta, S. K., Piccoli, M.-T., & Thum, T. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.002 · Cited by 43
Aging, MicroRNAs, and Heart Failure
Florio, M. C., Magenta, A., Beji, S., Lakatta, E. G., & Capogrossi, M. C. (2018) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.12.003 · Cited by 42
Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon?
Cianflone, E., Torella, M., Chimenti, C., Angelis, A. D., Beltrami, A. P., Urbanek, K., Rota, M., & Torella, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5813147 · Cited by 41
“With age, the expression of miR-22 has been found increased in the cardiac tissue [190].”
BackgroundRegulatory RNAs and Cardiovascular Disease – With a Special Focus on Circulating MicroRNAs
Dlouhá, D., & Hubacek, J. A. (2017) · Physiological Research · doi:10.33549/physiolres.933588 · Cited by 42
“Various miRNAs are known to exert key roles in ageing, and other miRNAs are encoded on sex chromosomes (Boon et al. 2013).”
MicroRNAs As Master Regulators of Atherosclerosis: From Pathogenesis to Novel Therapeutic Options
Hosen, M. R., Goody, P. R., Zietzer, A., Nickenig, G., & Jansen, F. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8107 · Cited by 43
“…mechanistic study showed that miR-34a interacts with protein phosphatase 1 nuclear-targeting subunit (PNUTS) to regulate the age-related induction of cardiomyocyte death, thus acting as a key regulator of cardiac repair and regeneration in the pathological remodeling of the heart after MI (17).”
InfluentialHistone Deacetylase SIRT1, Smooth Muscle Cell Function, and Vascular Diseases
Wang, F., & Chen, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.537519 · Cited by 43
“It has been well documented that non-coding RNAs have a role in the regulation of VDs and cellular senescence (Ito et al., 2010; Congrains et al., 2012; Abdelmohsen et al., 2013; Boon et al., 2013; Bielak-Zmijewska et al., 2014).”
BackgroundAdditive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis
Gatsiou, A., Georgiopoulos, G. A., Vlachogiannis, N. I., Pfisterer, L., Fischer, A., Sachse, M., Laina, A., Bonini, F., Delialis, D., Tual‐Chalot, S., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.005 · Cited by 42
Self-citationMicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1
McCubbrey, A. L., Nelson, J. D., Stolberg, V. R., Blakely, P. K., McCloskey, L., Janssen, W. J., Freeman, C. M., & Curtis, J. L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1401838 · Cited by 40
“The importance of miR-mediated disruption of gene translation in vivo has been shown in numerous pathways, including a model of LPS tolerance (34) and myocardial infarction (35).”
BackgroundUpadhya, B., Haykowsky, M. J., & Kitzman, D. W. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9714-z · Cited by 42
“MicroRNAs (miRNAs) have been implicated in cardiac aging and might have an important role in cardiac aging via effects on apoptosis, DNA damage, and telomere shortening [169].”
MicroRNA regulation of the major drug-metabolizing enzymes and related transcription factors
Dluzen, D. F., & Lazarus, P. J. (2015) · Drug Metabolism Reviews · doi:10.3109/03602532.2015.1076438 · Cited by 47
“miRNA have been identified as an ancient form of gene regulation and signaling and are involved in nearly every aspect of biology, including tissue development and homeostasis (Boon et al., 2013; Eulalio et al., 2012), oncogenesis (Calin et al.”
MiRNA Deregulation in Cardiac Aging and Associated Disorders
Verjans, R., van Bilsen, M., & Schroen, B. L. M. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.004 · Cited by 42
Exosomal microRNA-194 causes cardiac injury and mitochondrial dysfunction in obese mice
Nie, H., Pan, Y., & Zhou, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.113 · Cited by 39
Mechanisms of Neonatal Heart Regeneration
Cardoso, A. C., Pereira, A. H. M., & Sadek, H. A. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01282-5 · Cited by 42
Epigenetic dysregulation in cardiovascular aging and disease
Herman, A. B., Occean, J. R., & Sen, P. (2021) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2021.16 · Cited by 46
Lee, A.-T., Yang, M., Lee, Y., Yang, T., Wang, C., & Wang, C. (2021) · Antioxidants · doi:10.3390/antiox11010092 · Cited by 39
“In addition, miR-34a expression was induced in the ageing heart, and miR-34a inhibition alleviated age-associated cell death and fibrosis following myocardial infarction; PNUTS was identified as a novel direct target of miR-34a [46].”
BackgroundFan, F., Zhuang, J., Zhou, P., Liu, X., & Luo, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.22597 · Cited by 41
“For example, miR-34a is stimulated in the aging heart, and in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death by inducing DNA damage responses and telomere attrition [19].”
BackgroundKong, L., Han, Z., Zhao, M., Zhang, X., Zhuo, Y., Chai, Y., Li, Z., & Yuan, R. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02541 · Cited by 38
The Molecular Mechanisms in Senescent Cells Induced by Natural Aging and Ionizing Radiation
Ibragimova, M., Kussainova, A., Aripova, A., Bersimbaev, R. I., & Bulgakova, O. (2024) · Cells · doi:10.3390/cells13060550 · Cited by 45
Honeyman, L., Bazett, M., Tomko, T. G., & Haston, C. K. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-16 · Cited by 39
“For example, miR-34a has been shown to regulate cardiac function and ageing, in part through affecting fibrosis in this tissue [36] and miR-26a can also affect cardiac fibrosis through altering collagen I levels [37].”
BackgroundZhu, H., Wang, D., Yan, J., & Xu, J. (2015) · PubMed · Cited by 43
Recent insights into endothelial control of leukocyte extravasation
Hordijk, P. L. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2136-y · Cited by 41
“This directly relates to the signaling capacity of circulating microRNAloaded microvesicles and their potential to control leukocyte TEM and inflammation at distant sites [159], a topic which will very likely be addressed inmore detail the coming years.”
BackgroundMicroRNAs in injury and repair
Gerlach, C. V., & Vaidya, V. S. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1974-1 · Cited by 39
“In addition, miR34a has been implicated in aging-associated cardiomyocyte cell death and when inhibited in mice after MI reduced cell death and improved recovery of cardiac function (Boon et al. 2013).”
Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges
Bernardo, B. C., Gregorevic, P., Ritchie, R. H., & McMullen, J. R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01090 · Cited by 40
“, 2012b, 2014a, 2016b), and others (Boon et al., 2013; Yang et al., 2015), were able to show that inhibition of miR-34a or the miR-34 family is protective in the hearts of mice following a cardiac insult (but inhibition had no phenotypic effect in control mice), chronic inhibition of miR-34 may not be ideal because of…”
BackgroundInfluentialMicroRNAs, DNA damage response and ageing
Majidinia, M., Mir, S. M., Mirza‐Aghazadeh‐Attari, M., Asghari, R., Kafil, H. S., Safa, A., Mahmoodpoor, A., & Yousefi, B. (2020) · Biogerontology · doi:10.1007/s10522-020-09862-2 · Cited by 39
“It is shown that PNUTS plays an important role in regulating DDR. Inhibiting microRNA-34a has been resulted in increased rates of recovery after ischemic attacks and decreased fibrosis (Boon et al. 2013).”
BackgroundDombkowski, A. A., Batista, C. E. A., Cukovic, D., Carruthers, N. J., Ranganathan, R., Shukla, U., Stemmer, P. M., Chugani, H. T., & Chugani, D. C. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu276 · Cited by 42
“been reported (Somel et al. 2010; Li et al. 2011; Boon et al. 2013).”
miR-29 is an important driver of aging-related phenotypes
Swahari, V., Nakamura, A., Hollville, É., Hung, Y.-H., Kanke, M., Kurtz, C. L., Caravia, X. M., Roiz‐Valle, D., He, S., Krishnamurthy, J., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06735-z · Cited by 44
A CREB2-targeting microRNA is required for long-term memory after single-trial learning
Korneev, S. A., Vavoulis, D. V., Naskar, S., Dyakonova, V. E., Kemenes, I., & Kemenes, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-22278-w · Cited by 40
Li, F., Zhang, K., Xu, T., Du, W., Yu, B., Liu, Y., & Nie, H. (2018) · Endocrine · doi:10.1007/s12020-018-1753-7 · Cited by 37
Insufficient sleep is associated with a pro‐atherogenic circulating microRNA signature
Hijmans, J. G., Levy, M. V., Garcia, V. P., Lincenberg, G. M., Diehl, K. J., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2019) · Experimental Physiology · doi:10.1113/ep087469 · Cited by 39
“miR-34a promotes cellular senescence and dysfunction through the regulation of sirtuin-1 and the apoptotic protein BCL-2 (Boon et al., 2013).”
BackgroundInfluentialTakahashi, T., Shishido, T., Kinoshita, D., Watanabe, K., Toshima, T., Sugai, T., Narumi, T., Otaki, Y., Tamura, H., Nishiyama, S., et al. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.11.011 · Cited by 43
In vivo therapeutic genome editing via CRISPR/Cas9 magnetoplexes for myocardial infarction
Park, H., Kim, D., Cho, B., Byun, J., Kim, Y. S., Ahn, Y., Hur, J., Oh, Y., & Kim, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121327 · Cited by 40
microRNA-34 family: From mechanism to potential applications
Wang, C., Jia, Q., Guo, X., Li, K., Chen, W., Shen, Q., Xu, C., & Fu, Y. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106168 · Cited by 39
Sala, V., Bergerone, S., Gatti, S., Gallo, S., Ponzetto, A., Ponzetto, C., & Crepaldi, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1504-0 · Cited by 40
“A protein phosphatase 1 nuclear targeting subunit (Pnuts) was identified as a novel miR-34 target [72].”
BackgroundCircadian MicroRNAs in Cardioprotection
Oyama, Y., Bartman, C. M., Gile, J. J., & Eckle, T. D. L. G. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170707165319 · Cited by 38
“Examples of microRNAs found to increase cell death in IR-injury are miR-15 [38], miR-34 [39], miR-320 [40], miR-140 [41], miR-1/miR-206 [42], miR-92a [43], miR-122 [44], miR-150 [45], miR-181a [46] and miR-376b-5p [47].”
Lack of Cardiac Improvement After Cardiosphere-Derived Cell Transplantation in Aging Mouse Hearts
Zhao, Z., Han, X., Lei, W., Li, J., Yang, Z., Wu, J., Yao, M.-C., Lu, X., He, L., Chen, Y., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313005 · Cited by 41
Młynarska, E., Kowalik, A., Krajewska, A., Krupińska, N., Marcinkowska, W., Motor, J., Przybylak, A., Tłustochowicz, K., Rysz, J., & Franczyk, B. (2025) · Biomolecules · doi:10.3390/biom15101452 · Cited by 41
“Epigenetic changes and dysregulation of miRNAs (e.g., miR-34, miR-17-92) contribute to impaired contractility and fibrosis [47,48].”
The myriad essential roles of microRNAs in cardiovascular homeostasis and disease
Neppl, R. L., & Wang, D. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.06.003 · Cited by 36
Gupta, P., Liu, B., Wu, J. Q., Soriano, V., Vispo, E., Carroll, A. P., Goldie, B. J., Cairns, M. J., & Saksena, N. K. (2014) · Virology · doi:10.1016/j.virol.2013.12.026 · Cited by 39
Seeger, T., Xu, Q., Muhly-Reinholz, M., Fischer, A., Kremp, E.-M., Zeiher, A. M., & Dimmeler, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.04.002 · Cited by 37
Self-citationMicroRNAs Regulate TASK‐1 and Are Linked to Myocardial Dilatation in Atrial Fibrillation
Wiedmann, F., Kraft, M., Kallenberger, S., Büscher, A., Paasche, A., Blochberger, P. L., Seeger, T., Jávorszky, N., Warnecke, G., Arif, R., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023472 · Cited by 36
“49 Considering that AF is common in the aged population, miR-34a upregulation might play a role in the pathogenesis of AF.”
Self-citationYing, S., Chang, D. C., & Lin, S.-L. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7601-0_1 · Cited by 42
Pacurari, M., & Tchounwou, P. B. (2015) · International Journal of Inflammation · doi:10.1155/2015/101527 · Cited by 37
Site‐Directed RNA Editing with Antagomir Deaminases — A Tool to Study Protein and RNA Function
Vogel, P., & Stafforst, T. (2014) · ChemMedChem · doi:10.1002/cmdc.201402139 · Cited by 39
Cao, D., Jiang, C., Wan, C., Zhang, M., Zhang, Q., Zhao, M., Yang, B., Zhu, D., & Han, X. (2018) · Current Medical Science · doi:10.1007/s11596-018-1942-x · Cited by 37
Qin, X., Chang, F., Wang, Z., & Jiang, W. (2018) · Cancer Biomarkers · doi:10.3233/cbm-181301 · Cited by 36
miRNAs orchestration of cardiovascular diseases – Particular emphasis on diagnosis, and progression
Elsakka, E. G. E., Abulsoud, A. I., El‐Mahdy, H. A., Ismail, A., Elballal, M. S., Mageed, S. S. A., Khidr, E. G., Mohammed, O. A., Sarhan, O. M., Elkhawaga, S. Y., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154613 · Cited by 35
Age-related vascular gene expression profiling in mice
Rammos, C., Hendgen-Cotta, U. B., Deenen, R., Pohl, J., Stock, P., Hinzmann, C., Kelm, M., & Rassaf, T. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.01.001 · Cited by 39
Qiang, J., Zhu, X., He, J., Tao, Y., Bao, J.-W., Zhu, J.-H., & Xu, P. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00670 · Cited by 37
Non-coding RNAs in Cardiac Regeneration
Yuan, T., & Krishnan, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.650566 · Cited by 37
“Overexpression of miR-29 promotes apoptosis, whereas inhibition of miR-29 reduces cardiomyocyte apoptosis and infarct size in hearts subjected to I/R injury by decreasing the expression of pro-apoptotic molecular Bcl-2-associated X protein (Bax) and increasing anti-apoptotic molecular Bcl2 (Ye et al., 2010). miR-34a i…”
BackgroundAdverse Intrauterine Environment and Cardiac miRNA Expression
Lock, M. C., Botting, K. J., Tellam, R. L., Brooks, D. A., & Morrison, J. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122628 · Cited by 36
“miR-34a also regulates SIRT1 as well as PNUT that plays a role in DNA d mage resp nses and cardiomyocyte apoptosis [61].”
BackgroundUnraveling aging from transcriptomics
Huang, Y., Zhu, S., Yao, S., Zhai, H., Liu, C., & Han, J. J. (2024) · Trends in Genetics · doi:10.1016/j.tig.2024.09.006 · Cited by 36
Bhattacharjee, S., Zhao, Y., & Lukiw, W. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00116 · Cited by 34
Kukreti, H., & Amuthavalli, K. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29312 · Cited by 37
“in heart and vascular aging.(17) Elevated expression of miR‐34a in the aged heart led to cell death, while inhibition of miR‐34a protected cardiomyocytes from cell death.”
BackgroundMethodDong, M., Yang, Z., Fang, H., Xiang, J., Xu, C., Zhou, Y., Wu, Q., & Liu, J. (2020) · Aging and Disease · doi:10.14336/ad.2019.0522 · Cited by 36
Therapeutic Value of miRNAs in Coronary Artery Disease
Sheikh, M. S. A., Alduraywish, A. A., Almaeen, A. H., Alruwali, M., AlRuwaili, R., Alomair, B. M., Salma, U., Mostafa‐Hedeab, G., Bugti, N., & Abdulhabeeb, I. A. M. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8853748 · Cited by 38
“Protein phosphatase 1 regulatory subunit 10 (PPP1R10) is the target gene for miR-34a [89].”
BackgroundMicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
Kuang, Z., Wu, J., Tan, Y. C., Zhu, G., Li, J., & Wu, M. (2023) · Biomolecules · doi:10.3390/biom13030568 · Cited by 36
Hao, Y., & Zhou, Q. (2016) · Journal of Clinical & Experimental Ophthalmology · doi:10.4172/2155-9570.1000562 · Cited by 34
“One particular example is miR-34a, which is upregulated during aging and regulates cell senescence, life-span and aging in multiple species [8-14].”
BackgroundPathways for salvage and protection of the heart under stress: novel routes for cardiac rejuvenation
Cannata, A. N., Camparini, L., Sinagra, G., Giacca, M., & Loffredo, F. S. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw106 · Cited by 35
Developing miRNA therapeutics for cardiac repair in ischemic heart disease
Zhu, K., Liu, D., Lai, H., Li, J., & Wang, C. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.08.93 · Cited by 33
“The inhibition of miRNA-34, which targets the vascular deacetylase Sirt1, also exhibited cardioprotective effect (28,29).”
BackgroundCardiac telomere length in heart development, function, and disease
Booth, S. A., & Charchar, F. J. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2017 · Cited by 39
Targeting TGFβ Signaling to Address Fibrosis Using Antisense Oligonucleotides
March, J. T., Golshirazi, G., Cernisova, V., Carr, H., Leong, Y., Lu‐Nguyen, N., & Popplewell, L. J. (2018) · Biomedicines · doi:10.3390/biomedicines6030074 · Cited by 37
“Finally, AO-mediated inhibition of miR-34a appeared to reduce fibrosis following myocardial infarction in rats [110]; while targeting miR-34a, -b and -c likewise reduced cardiac fibrosis improved systolic function in mice subjected to pressure overload [111].”
BackgroundDeletion of miR-126a Promotes Hepatic Aging and Inflammation in a Mouse Model of Cholestasis
Yan, Y. L., Qin, D., Hu, B., Zhang, C., Liu, S., Wu, D., Huang, W., Huang, X., Wang, L., Chen, X., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.04.002 · Cited by 39
Weng, C.-F., Wu, C., Kao, S., Chen, R. J., & Lin, H. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01445 · Cited by 33
RetractedEndothelial and systemic upregulation of miR-34a-5p fine-tunes senescence in progeria
Manakanatas, C., Ghadge, S. K., Agic, A., Sarigol, F., Fichtinger, P., Fischer, I., Foisner, R., & Osmanagic‐Myers, S. (2022) · Aging · doi:10.18632/aging.203820 · Cited by 38
“This suggested, in addition to the systemic also a cumulative effect of this miR on several targets in the Prog-Tg transcriptome. miR34a-5p fine-tunes senescence in progerinexpressing ECs Given the above observations implying a systemic relevance of miR34-5p and its potential involvement in CVD pathology in Prog-Tg mi…”
BackgroundInfluentialTREM2 signaling, miRNA-34a and the extinction of phagocytosis
Zhao, Y., & Lukiw, W. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00131 · Cited by 33
“…(Agostini et al., 2011) and deficient immune and phagocytotic responses in inflammatory degenerative disorders such as cardiovascular disease (Boon et al., 2013), multiple sclerosis (Junker et al., 2009), and in sporadic AD mononuclear cells (Schipper et al., 2007) as well as in AD brain…”
BackgroundThe mirn23a microRNA cluster antagonizes B cell development
Kurkewich, J. L., Bikorimana, E., Nguyen, T. A., Klopfenstein, N., Zhang, H., Hallas, W. M., Stayback, G., McDowell, M. A., & Dahl, R. E. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1hi0915-398rr · Cited by 36
miR-34a-5p regulates PINK1-mediated mitophagy via multiple modes
Tai, Y., Pu, M., Yuan, L., Guo, H., Qiao, J., Lu, H., Wang, G., Chen, J., Qi, X., Tao, Z., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119415 · Cited by 33
MicroRNA regulation of autophagy in cardiovascular disease
Zhu, H. (2016) · Frontiers in bioscience · doi:10.2741/4471 · Cited by 33
“Up-regulated in Type 2 diabetes patients with ischemic HF (82,97)”
BackgroundEffects of microwave on extracellular vesicles and microRNA in milk
Zhao, Z., Yu, S., Xu, M., & Li, P. (2018) · Journal of Dairy Science · doi:10.3168/jds.2016-12021 · Cited by 32
“…in Caenorhabditis elegans (Lee et al., 1993), which have been recognized as playing a crucial role in a wide range of physiological processes, including developmental timing (Lee and Ambros, 2001), cell proliferation and apoptosis (Boon et al., 2013), and immune response (Rodriguez et al., 2007).”
Endothelial Cell Aging: How miRNAs Contribute?
Yamakuchi, M., & Hashiguchi, T. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7070170 · Cited by 32
“Reduction of miR-34a inhibited myocardial infarction-induced cell death of cardiomyocytes and cardiac function in aged mice [89].”
BackgroundMicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death
Jiao, D., Zhang, H., Jiang, Z., Huang, W., Liu, Z., Wang, Z., Wang, Y., & Wu, H. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1667-0 · Cited by 32
miR-34a is a common link in both HIV- and antiretroviral therapy-induced vascular aging
Zhan, J., Qin, S., Lu, L., Hu, X., Zhou, J., Sun, Y., Yang, J., Liu, Y., Wang, Z., Tan, N., et al. (2016) · Aging · doi:10.18632/aging.101118 · Cited by 32
“com 3299 AGING (Albany NY) of vascular endothelial cells (ECs) from patients with vascular disease [12-16].”
Oxidative Stress-Induced Ferroptosis in Cardiovascular Diseases and Epigenetic Mechanisms
Li, J., Zhou, Y., Wang, H., Lou, J., Lenahan, C., Gao, S., Wang, X., Deng, Y., Chen, H., & Shao, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.685775 · Cited by 42
Kapoor, R., Arora, S., Ponia, S. S., Kumar, B., Maddika, S., & Banerjea, A. C. (2015) · Biochemical Journal · doi:10.1042/bj20150700 · Cited by 33
Kelm, N. Q., Piell, K. M., Wang, E., & Cole, M. P. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26283 · Cited by 31
“…miRNA-133a, and miRNA-34a expression and implicated mostly in the age-dependent changes in the cardiac signaling pathway of old heart and MI (Bernardo et al., 2012; Boon et al., 2013; Huang, Qi, Du, & Zhang, 2014; Murach & McCarthy, 2017; Saba et al., 2012; van de Vrie, Heymans, & Schroen, 2011).”
BackgroundGomes, C. P. C., de Gonzalo‐Calvo, D., Toro, R., Fernandes, T. M., Theisen, D., Wang, D., Devaux, Y., & on behalf of the Cardiolinc™ network (2018) · Clinical Science · doi:10.1042/cs20171463 · Cited by 32
Biliczki, P., Boon, R. A., Girmatsion, Z., Bukowska, A., Ördög, B., Kaess, B. M., Hohnloser, S. H., Goette, A., Varró, A., Moritz, A., et al. (2019) · EP Europace · doi:10.1093/europace/euz135 · Cited by 31
Self-citationAdvances in epigenetic regulation of vascular aging
Jin, J., Liu, Y., Huang, L., & Tan, H. (2019) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2019.01.3189 · Cited by 33
“It has been reported that upregulation of mir-34a in senescent endothelial cells and endothelial progenitor cells inhibited cell proliferation that progressed cellular senescence and decreased mice lifespan (Boon et al., 2013).”
BackgroundMiR-185 targets POT1 to induce telomere dysfunction and cellular senescence
Li, T., Luo, Z., Song, L., Li, C., Dai, S., Wang, H., Huang, J., Ma, W., Songyang, Z., & Huang, Y. Y. (2020) · Aging · doi:10.18632/aging.103541 · Cited by 35
“For example, miR-34a is induced during the aging process and increases age-related and myocardial infarctioninduced cardiomyocyte cell death [20].”
BackgroundMicroRNAs in vascular tissue engineering and post-ischemic neovascularization
Caputo, M., Saif, J., Rajakaruna, C., Brooks, M. J., Angelini, G. D., & Emanueli, C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.003 · Cited by 30
“By contrast, miR-34 inhibition by seed-targeting 8-mer locked nucleic acid (LNA)-modified antimiR (LNA-antimiR-34) promoted angiogenesis in mouse ischemic models [76, 77].”
BackgroundPrecision Cardio-oncology: Update on Omics-Based Diagnostic Methods
Kuang, Z., Kong, M., Yan, N., Ma, X., Wu, M., & Li, J. P. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01203-6 · Cited by 31
“MiRNA controls the basic functions of almost all cell types associated with the cardiovascular system, especially endothelial cells and cardio-myocytes [43, 44].”
BackgroundmicroRNAs in kidney diseases: Regulation, therapeutics, and biomarker potential
Liu, Z., Fu, Y., Yan, M., Zhang, S., Cai, J., Chen, G., & Dong, Z. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108709 · Cited by 30
Statins in Mitigating Anticancer Treatment-Related Cardiovascular Disease
Jiang, R., Lou, L., Shi, W., Chen, Y., Fu, Z., Liu, S., Sok, T., Li, Z., Zhang, X., & Yang, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810177 · Cited by 34
“Radiation-induced miRNA-34a accelerates genetic aging and shortens and deactivates nuclear telomeres, leading to cardiac myocyte aging and damage [64,65].”
BackgroundLiu, J., Li, K., Yi, Z., Saqirile, Wang, C., & Yang, R. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080614 · Cited by 36
“In contrast, miR-34a inhibition attenuates cardiomyocyte death and fibrosis, thereby improving cardiac function [78].”
Impact of miRNAs on cardiovascular aging.
Lee, S., Choi, E., Cha, M., Park, A.-J., Yoon, C., & Hwang, K. (2015) · 老年心脏病学杂志:英文版 · doi:10.11909/j.issn.1671-5411.2015.05.011 · Cited by 33
Possible Muscle Repair in the Human Cardiovascular System
Sommese, L., Zullo, A., Schiano, C., Mancini, F. P., & Napoli, C. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9711-3 · Cited by 31
A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer
Kong, J., & Wang, W. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s234549 · Cited by 30
Zhu, S., Fisher, L. A., Bessho, T., & Peng, A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx686 · Cited by 33
“Expression of PNUTS suppressed the apoptosis of cardiomyocytes treated with DNA damaging agents (27).”
BackgroundNon-coding RNAs as orchestrators of autophagic processes
Gupta, S. K., & Thum, T. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.012 · Cited by 30
Wang, X., Shang, Y., Dai, S., Wu, W., Fan, Y., & Cheng, L. (2019) · Current Neurovascular Research · doi:10.2174/1567202617666191223142743 · Cited by 29
Yang, Z., Guo, Y., Zhou, J., Liu, F., Liang, W., Chai, Y., Li, Z., & Yuan, R. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04037 · Cited by 29
Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?
Philippen, L. E., Dirkx, E., Wit, J. B. M., Burggraaf, K., Windt, L. J. D., & Martins, P. A. D. C. (2015) · Molecular Therapy · doi:10.1038/mt.2015.133 · Cited by 36
Metadata
- Authors
- Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., Horrevoets, A. J. G., Didier, N., Girmatsion, Z., Biliczki, P., Ehrlich, J. R., Katus, H. A., Müller, O. J., Potente, M., Zeiher, A. M., Hermeking, H., & Dimmeler, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Pathologisches Institut (DE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- Heidelberg University (DE)
- Corresponding author
- Dimmeler, Stefanie
- ORCID
- Venue
- Nature
- Published
- 2013-02-20
- Volume
- 495
- Issue
- 7439
- Pages
- 107-110
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090374150
- Cited by
- 821
- References
- 36
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 41 · 2023: 42 · 2022: 64 · 2021: 45 · 2020: 61 · 2019: 59 · 2018: 72 · 2017: 84 · 2016: 75 · 2015: 85 · 2014: 90 · 2013: 34
- FWCI
- 33.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- miR-34a, cardiac aging, PNUTS, microRNA regulation, cardiomyocyte apoptosis, telomere shortening, DNA damage response, myocardial fibrosis, acute myocardial infarction, cardiac contractile function, therapeutic target
- MeSH terms
- Aging, Animals, DNA Damage, Fibrosis, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardial Infarction, Myocardium, Substrate Specificity, Genetic Therapy, Telomere, Apoptosis, Gene Deletion, Myocytes, Cardiac, MicroRNAs, Mice, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.